Angola vs Niger: Population requiring preventive chemotherapy for schistosomiasis
Angola
5.62 million
in 2024
Niger
5.10 million
in 2024
Angola rank
13th
Niger rank
16th
Population requiring preventive chemotherapy for schistosomiasis over time
- Angola
- Niger
How they compare
Angola currently reports 5.62 million against 5.10 million in Niger, a difference of 519,370.
That makes Angola's figure about 1.1 times Niger's.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Niger ahead.
Angola ranks 13th and Niger ranks 16th of 52 countries.
Across the 2 decades both report, Angola averaged higher in 1 and Niger in 1.
Head to head by decade
| Decade | Angola | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.53 million | 5.02 million | 509,901 | Angola |
| 2020s | 5.29 million | 8.69 million | 3.40 million | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Angola or Niger?
- Angola, at 5.62 million against 5.10 million in Niger as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Angola and Niger?
- 519,370, with Angola ahead.
- How many years of comparable data are there for Angola and Niger?
- 15 years are reported by both, from 2010 to 2024.
- How do Angola and Niger rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Angola ranks 13th and Niger ranks 16th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.